Company Profiles

driven by the PitchBook Platform

Evolve BioSystems

Evolve BioSystems
2012 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$20M LATEST DEAL AMOUNT
$30M TOTAL AMOUNT RAISED
Description

Provider of microbiome-based products. The company provides microbiome-based products to establish, restore, and maintain a healthy gut microbiome and improve life-long health trajectory. The Company's initial focus is on products to establish and maintain the healthy gut microbiome in newborn infants with a consumer-directed home use product, and a hospital-based neonatal ICU product.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare
Other Healthcare Services
Primary Office
2121 2nd Street
B-107
Davis, CA 95618
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Evolve BioSystems’s full profile, request a free trial.

Evolve BioSystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 30-May-2017 $20M $30M 0000 Completed Generating Revenue/Not Profitable
2. Early Stage VC (Series A) 17-Aug-2015 000 0000 0000 Completed Startup
1. Seed Round 15-Sep-2014 $1M $1M $4.3M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Evolve BioSystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Seed 725,098 $0.000100 $0.05 $1.32 $1.32 1x $1.32 8.11%
To view this company’s complete Cap Table request access »

Evolve BioSystems Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Acre Venture Partners Corporate Venture Capital Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
Bow Capital Venture Capital Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0
Horizons Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Evolve BioSystems Executive Team (5)

Name Title Board
Seat
Contact
Info
Timothy Brown Chief Executive Officer & Board Member
Susan Vandegrift Chief Financial Officer
David Kyle Ph.D Co-Founder , Executive Chairman & Chief Scientific Officer
Samara Freeman Ph.D Co-Founder & Director, Intellectual Property & Regulatory Affairs
Christie Fleming Senior Vice President of Marketing

You’re viewing 5 of 5 executives.

Evolve BioSystems Board Members (7)

Name Representing Role Since Contact
Info
Daniel Janney Alta Partners Board Member 000 0000
David Kyle Ph.D Evolve BioSystems Co-Founder , Executive Chairman & Chief Scientific Officer 000 0000
Gareth Asten Acre Venture Partners Board Member 000 0000
Patrick Zhang Horizons Ventures Board Member 000 0000
Roger Wyse Ph.D Spruce Capital Partners Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »